PHIO PHARMACEUTICALS CORP (PHIOXXXX)
Institutional ownership reported to the SEC as of Q4 2019, across 5 quarters.
7
Reporting holders
$220.0K
Reported value
0.0%
Held as options
-1
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| UBS Group AG | $427.0K | 45,409 | 0.00% | 4q | +43.3%+$129.0K |
| SG Americas Securities, LLC | $135.0K | 792,374 | 0.00% | 5q | +12.3%+$14.8K |
| RENAISSANCE TECHNOLOGIES LLC | $57.0K | 333,890 | 0.00% | 4q | +585.9%+$48.7K |
| Virtu Financial LLC | $17.0K | 96,955 | 0.00% | new | NEW |
| VANGUARD GROUP INC | $5.0K | 26,460 | 0.00% | 5q | HELD |
| HSBC HOLDINGS PLC | $5.0K | 29,370 | 0.00% | new | NEW |
| MORGAN STANLEY | $1.0K | 4,810 | 0.00% | 5q | HELD |
| Kelly Financial Services LLC | $1 | 5 | 0.00% | 4q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q4 2019 | 7 | $220.0K | 1,283,864 | 2 | 2 | 0 | 0.0% |
| Q3 2019 | 8 | $259.0K | 943,160 | 0 | 2 | 3 | 0.0% |
| Q2 2019 | 10 | $909.0K | 2,395,233 | 0 | 7 | 1 | 0.0% |
| Q1 2019 | 12 | $591.0K | 1,313,293 | 6 | 3 | 0 | 0.0% |
| Q4 2018 | 7 | $647.0K | 1,956,876 | 2 | 0 | 0 | 0.0% |